Mercury Laboratories Ltd

Mercury Laboratories Ltd

₹ 832 0.63%
20 May - close price
About

Incorporated in 1962, Mercury Laboratories
Ltd manufactures and exports Pharmaceutical items of gynec and pediatrics

Key Points

Product Categories:[1]
Analgesic, Anti-inflammatory, Anti-pyretic, Anthelmintic, Antibiotic, Anti-coagulant,
Anti- platelet, Bleeding agents, Anti-fungal, Anti-hypertensive drugs, Anti malarial drugs, Cardiovascular System, Central Nervous System, Eye, Gastro-intestinal system, Hypoglycemic (Anti-diabetic), Multivitamin, Protein supplement, Respiratory System, Anti- allergic, Steroids, Urinary system, Uterine stimulant, Tablets, Oral Liquids, Small Volume Parenterals, Eye/Ear Drops

  • Market Cap 99.8 Cr.
  • Current Price 832
  • High / Low 1,190 / 736
  • Stock P/E 31.8
  • Book Value 446
  • Dividend Yield 0.42 %
  • ROCE 9.03 %
  • ROE 6.01 %
  • Face Value 10.0

Pros

Cons

  • The company has delivered a poor sales growth of 5.57% over past five years.
  • Company has a low return on equity of 10.0% over last 3 years.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Loading peers table ...

Quarterly Results

Figures in Rs. Crores

Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025
13.33 17.60 22.07 16.23 19.43 18.32 22.76 17.11 17.37 16.68 18.19 19.57 20.66
12.15 15.33 17.39 15.65 18.39 16.66 20.28 14.88 14.71 15.07 16.88 17.59 18.53
Operating Profit 1.18 2.27 4.68 0.58 1.04 1.66 2.48 2.23 2.66 1.61 1.31 1.98 2.13
OPM % 8.85% 12.90% 21.21% 3.57% 5.35% 9.06% 10.90% 13.03% 15.31% 9.65% 7.20% 10.12% 10.31%
0.57 0.49 0.22 0.58 0.43 0.15 0.36 0.18 0.41 0.15 0.21 0.53 0.18
Interest 0.04 0.09 0.09 0.08 0.10 0.08 0.11 0.10 0.10 0.14 0.15 0.13 0.13
Depreciation 0.62 0.61 0.62 0.63 0.62 0.68 0.71 0.72 0.72 0.70 0.71 0.74 0.73
Profit before tax 1.09 2.06 4.19 0.45 0.75 1.05 2.02 1.59 2.25 0.92 0.66 1.64 1.45
Tax % 24.77% 28.64% 25.06% -35.56% 50.67% 5.71% 25.74% 22.01% 15.11% 63.04% 22.73% 27.44% 23.45%
0.83 1.46 3.14 0.61 0.37 1.00 1.51 1.24 1.91 0.34 0.50 1.19 1.11
EPS in Rs 6.92 12.17 26.17 5.08 3.08 8.33 12.58 10.33 15.92 2.83 4.17 9.92 9.25
Raw PDF

Profit & Loss

Figures in Rs. Crores

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
41.45 41.19 47.51 48.02 51.86 55.52 57.27 68.60 57.92 75.33 75.56 75.10
35.08 35.40 41.04 41.30 47.44 49.79 51.10 59.01 50.92 66.73 66.53 68.08
Operating Profit 6.37 5.79 6.47 6.72 4.42 5.73 6.17 9.59 7.00 8.60 9.03 7.02
OPM % 15.37% 14.06% 13.62% 13.99% 8.52% 10.32% 10.77% 13.98% 12.09% 11.42% 11.95% 9.35%
0.79 1.12 0.78 0.35 0.42 1.04 0.85 0.88 0.94 1.69 1.09 1.07
Interest 1.47 1.12 1.13 0.89 0.91 1.09 0.82 0.64 0.45 0.36 0.38 0.55
Depreciation 0.89 1.18 1.18 1.29 1.47 1.63 1.87 1.92 2.45 2.48 2.82 2.88
Profit before tax 4.80 4.61 4.94 4.89 2.46 4.05 4.33 7.91 5.04 7.45 6.92 4.66
Tax % 32.71% 27.98% 20.45% 44.79% 17.89% 29.88% 25.40% 32.49% 29.17% 24.97% 18.35% 32.62%
3.22 3.31 3.92 2.70 2.01 2.84 3.23 5.34 3.56 5.58 5.65 3.14
EPS in Rs 26.83 27.58 32.67 22.50 16.75 23.67 26.92 44.50 29.67 46.50 47.08 26.17
Dividend Payout % 5.59% 5.44% 4.59% 6.67% 8.96% 6.34% 7.43% 7.87% 11.80% 7.53% 7.43% 13.38%
Compounded Sales Growth
10 Years: 6%
5 Years: 6%
3 Years: 9%
TTM: -1%
Compounded Profit Growth
10 Years: -1%
5 Years: -1%
3 Years: -3%
TTM: -44%
Stock Price CAGR
10 Years: 32%
5 Years: 12%
3 Years: 20%
1 Year: -7%
Return on Equity
10 Years: 11%
5 Years: 11%
3 Years: 10%
Last Year: 6%

Balance Sheet

Figures in Rs. Crores

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity Capital 1.20 1.20 1.20 1.20 1.20 1.20 1.20 1.20 1.20 1.20 1.20 1.20
Reserves 14.21 16.94 20.65 23.27 25.15 27.77 30.78 35.69 39.11 44.43 49.64 52.37
11.24 8.88 7.37 7.44 9.76 9.56 7.19 7.10 5.99 5.83 5.55 5.45
13.56 15.50 17.30 19.23 15.59 18.76 17.13 21.38 16.14 12.70 11.57 15.22
Total Liabilities 40.21 42.52 46.52 51.14 51.70 57.29 56.30 65.37 62.44 64.16 67.96 74.24
19.48 19.48 18.57 18.39 20.78 24.39 23.66 26.36 25.82 24.26 24.03 24.64
CWIP 0.00 0.00 0.00 0.40 0.24 0.00 0.00 0.00 0.00 0.13 3.82 9.32
Investments 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01
20.72 23.03 27.94 32.34 30.67 32.89 32.63 39.00 36.61 39.76 40.10 40.27
Total Assets 40.21 42.52 46.52 51.14 51.70 57.29 56.30 65.37 62.44 64.16 67.96 74.24

Cash Flows

Figures in Rs. Crores

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
3.47 3.49 -0.10 1.92 4.97 5.22 5.49 8.21 5.19 2.45 8.23 4.00
-2.48 -1.54 -0.28 -1.50 -3.68 -4.99 -1.14 -4.62 -1.89 -1.06 -6.27 -9.04
-1.04 -2.12 0.47 -0.25 1.07 -2.54 -3.33 -1.24 -1.23 -1.01 -1.04 -0.99
Net Cash Flow -0.05 -0.18 0.09 0.17 2.36 -2.31 1.02 2.36 2.07 0.38 0.91 -6.03

Ratios

Figures in Rs. Crores

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Debtor Days 104.70 107.84 103.02 133.25 103.60 126.82 115.61 119.93 105.49 103.55 105.55 125.10
Inventory Days 72.20 93.92 115.50 137.30 119.80 93.95 78.44 60.42 104.59 82.82 74.81 91.00
Days Payable 135.37 159.39 136.34 186.56 138.65 161.71 120.01 137.94 105.98 76.58 62.40 124.06
Cash Conversion Cycle 41.53 42.37 82.19 83.99 84.75 59.05 74.04 42.41 104.10 109.79 117.96 92.03
Working Capital Days 33.90 44.22 75.52 102.84 90.58 88.75 88.78 75.02 98.50 103.35 102.94 118.98
ROCE % 25.68% 21.35% 21.59% 18.91% 9.82% 13.77% 13.26% 20.56% 11.83% 16.04% 13.41% 9.03%

Shareholding Pattern

Numbers in percentages

Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025
73.66% 73.66% 73.66% 73.66% 73.66% 73.66% 73.66% 73.66% 73.66% 73.66% 73.66% 73.66%
26.34% 26.35% 26.34% 26.35% 26.35% 26.34% 26.35% 26.34% 26.35% 26.36% 26.34% 26.34%
No. of Shareholders 1,1821,1851,1871,1461,1191,1491,1611,2141,2591,3451,4111,397

Documents